Skip to main content

Raphael Pessoa Nunes Accepts Sanction for Second Violation of UFC Anti-Doping Policy

Raphael Pessoa Nunes Accepts Sanction for Second Violation of UFC Anti-Doping Policy

Press Release

4th May 2021

USADA announced today that Raphael Pessoa Nunes, of Sao Paulo, Brazil, has accepted a two-year sanction for his second violation of the UFC® Anti-Doping Policy involving his use and/or attempted use of a prohibited substance, positive tests for that substance, and evasion of sample collection. As required under the rules and described below, the three violations were combined into a single second violation. Pessoa Nunes’ received his first violation after testing positive for the same substance and served a one-year period of ineligibility beginning on March 4, 2020.

Pessoa Nunes, 32, tested positive for hydrochlorothiazide (HCTZ) and its metabolites chlorothiazide and 4-amino-6-chloro-1,3-benzenedisulfonamide (ACB) as the result of urine samples collected out-of-competition on February 9, 2021, February 15, 2021, February 16, 2021, and March 4, 2021. HCTZ is a Specified Substance in the class of Diuretics and Masking Agents and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List. Because Pessoa Nunes was not yet notified of the positive tests until after all four samples were collected, they were treated as a single second violation.

The athlete also evaded sample collection on January 25, 2021 and January 28, 2021. Evading sample collection, or refusing or failing to submit to sample collection, without compelling justification is a doping violation under the UFC Anti-Doping Policy. Pessoa Nunes had not been notified of the evasion violations until after his positive tests were reported. Therefore, the evasion violations were also combined into the single second violation.

Pessoa Nunes’ period of ineligibility began on February 9, 2021, the date his first positive sample was collected.

Leave a comment

Please login to leave a comment.

Upcoming Events

There are no up-coming events